that this gene pair directly mediates CI.
LePage and colleagues expressed cifA and cifB sequences in Drosophila melanogaster fruit flies. When these genes were expressed in the germ line of males mated to females that did not express cifA and cifB, the offspring had reduced hatch rates and embryonic celldivision defects that were strikingly similar to those observed in CI. The hatch rate was restored when males flies expressing cifA and cifB were mated to Wolbachia-infected females.
The findings by LePage et al. are consistent with the work of Beckmann and colleagues. Previous studies 7 by Beckmann et al. identified a protein called WPA0282 that is present in sperm from males infected with the Wolbachia strain wPip. In the operon sequence that encodes the WPA0282 protein (renamed CidA by Beckmann et al.) , the authors identified a gene they called cidB. This gene encodes a deubiquitylating enzyme, an enzyme that can remove ubiquitin proteins attached to other proteins. Such bound ubiquitins often act as a tag that targets a protein for destruction. When D. melanogaster males expressing CidA and CidB proteins in their germ line were mated with female flies that were not infected with Wolbachia, the offspring had the type of nuclear abnormalities during early embryonic divisions that are characteristic of CI.
It seems likely that cifA and cifB identified by LePage and colleagues are the same as (or related to) cidA and cidB identified by Beckmann and colleagues. The relationship between these genes, which were identified in different Wolbachia strains, will require further investigation.
If a deubiquitylating enzyme is responsible for CI induction, where does it localize, and what are its targets? What pathway connects the action of the identified genes to the observed embryonic defects in CI, and how does rescue of CI occur? Researchers are now positioned to rapidly address many of these important questions. 
William Sullivan is in the Department
here has been an upsurge in interest in the use of Wolbachia bacteria to control mosquito-transmitted viruses such as dengue and Zika -devastating diseases that threaten about half of the world's population 8 . Most of the current control measures for these diseases are proving to be ineffective.
Two main Wolbachia-based diseasecontrol methods are being tested in the field. The first approach targets virus replication in mosquitoes. Wolbachia prevents a range of human viruses and parasites, such as dengue, chikungunya and Zika virus, from replicating in the Aedes aegypti mosquito. If Wolbachia can be successfully introduced into natural populations of these mosquitoes, it should greatly reduce the disease-transmission potential of the insect populations (Fig. 1) . It is thought that the Wolbachia-mediated pathogeninterference mechanism involves a combination of upregulated mosquito immune pathways and competition for key lipid mol ecules such as cholesterol 9 . The second approach uses Wolbachia to directly suppress the abundance of mosquito populations and thereby reduce viral transmission. Both approaches rely on the CI phenomenon for their success.
For disease-control approaches that introduce Wolbachia into mosquito populations, such as the work being carried out by the Eliminate Dengue Program 10 , CI is the central mechanism that allows Wolbachia to become established and maintain itself sustainably in the mosquito population. In the alternative suppression approach, the embryo mortality that CI induces is being used to reduce the mosquito population over time. In this approach, male mosquitoes are released that are infected with a Wolbachia strain that will induce CI in matings with wild females.
A deeper understanding of the CI mechanism from the work by LePage et al. and Beckmann et al. opens the door for manipulating the system and potentially tuning Wolbachiainduced CI to enhance the ability of different Wolbachia strains to invade insect populations. Perhaps the CI mechanism can be separated from the pathogen-blocking effects of different Wolbachia strains so that better strains for insect treatment can be generated. It might be possible in future to genetically engineer Wolbachia strains to replace strains that have been previously used in control programmes as a way of managing resistance issues, if Wolbachia were to lose effectiveness over time. Understanding CI might enable this phenomenon to be used in other insect species that Wolbachia does not naturally infect, or that are resistant to Wolbachia infection.
Many of these potential approaches would require the release of genetically modified insects into the environment. Recent controversy in Florida about the release of genetically modified mosquitoes for control of mosquitotransmitted viruses indicates that technology alone is insufficient for programmes to be successfully implemented in the field, and public understanding and acceptance are required for such technologies to be effective. ■ 
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K A R E N A D E L M A N & E M I LY E G A N
I n addition to protein-coding messenger RNAs, our cells produce a plethora of diverse non-coding RNA molecules. Many of these are generated from sequences that are distant from genes, and include regulatory DNA sequences called enhancers 1 .
Transcription factors bound at enhancers are thought to regulate gene expression by looping towards genes in 3D space. The potential functions of non-coding enhancer RNAs (eRNAs) in this process have been avidly debated, but there has been a tendency to write them off as accidentally transcribed by-products of enhancer-gene interactions. After all, how NON-CODING RNA
More uses for genomic junk
It emerges that nascent non-coding RNAs transcribed from regulatory DNA sequences called enhancers bind to the enzyme CBP to promote its activity locally. In turn, the activities of CBP stimulate further enhancer transcription.
could short, unstable, heterogeneous RNAs have a role in gene regulation? Writing in Cell, Bose et al. 2 reveal that these eRNAs can indeed be functional, when produced in proximity to the enzyme CBP.
Many proteins that modulate gene expression have RNA-binding surfaces 3, 4 -this includes DNA-binding transcriptional regulators, as well as epigenetic factors, which add or remove molecular modifications to DNA and other regulatory proteins. However, there are few examples of these RNA-protein interactions modulating an enzyme's catalytic activity. One exception is the interaction between RNA and the enzyme PRC2, which deposits repressive methyl groups on histone proteins, around which DNA is packaged in a structure called chromatin. Nascent transcription prevents PRC2 from depositing methyl groups onto histones in the vicinity, helping to maintain gene activity 5, 6 . Bose and colleagues now show that this phenomenon of local regulation by non-coding RNA might be general, affecting transcriptional co-activator proteins as well as repressors such as PRC2.
One transcriptional co-activator is the acetyltransferase enzyme CBP, which, along with its close relative p300, associates with DNA in enhancer regions 7 , where it adds acetyl groups to histones and transcription factors. This acetylation promotes the recruitment of numerous transcriptional co-activators and chromatin-remodelling proteins that have acetyl-binding regions, along with the RNA-synthesizing enzyme polymerase II (Pol II). The authors began by isolating and sequencing thousands of RNA molecules that interact with CBP in vivo. Most CBP-bound RNAs were derived from intergenic regions and non-coding intron sequences that lie within genes, rather than protein-coding exon sequences. Moreover, the RNAs typically originated from DNA regions to which CBP binds, including enhancers.
Indicating that many of the CBP-bound RNAs are eRNAs, these transcripts seemed to be generally unstable. The researchers detected low or undetectable levels of these molecules on examination of all the RNA molecules present in the cell, but a prominent proportion in an assay of all nascent RNAs. Moreover, CBP-bound RNA levels correlated with both nascent RNA levels and CBP-binding intensity in a given region, suggesting that interactions occur on chromatin between CBP and newly transcribed RNAs (Fig. 1) .
Bose et al. went on to define the primary region in CBP that interacts with RNA as a disordered, basic loop within the protein's acetyltransferase domain. This region had previously 8 been defined as an auto-inhibitory domain whose action could be relieved by regulated auto-acetylation. This suggested that neutralization of positive charges in the basic loop -by either acetyl groups or nucleic acids, both of which are negatively chargedcould stimulate the acetyltransferase activity of CBP. The authors found that various RNAs bound CBP with low affinity and little sequence specificity, consistent with a promiscuous RNA-binding site, as observed 6,7 for PRC2. Strikingly, RNA binding to this domain stimulated acetyltransferase activity in vitro, supporting the idea that RNA binding relieves auto-inhibition by the basic loop and regulates acetylation levels.
Of note, there was previous evidence 7 that the catalytic activity of CBP and p300 is regulated at enhancers. Histone acetylation by these proteins is a hallmark of active enhancers that are communicating with their target genes to stimulate transcription. But CBP and p300 are also found associated with inactive enhancers, which lack histone acetylation. Accordingly, although CBP and p300 are bound at most enhancers, their levels on DNA do not effectively predict the expression of target genes 7 . By contrast, when focusing only on enhan cers that generated CBP-bound eRNAs, Bose et al. found that the depletion of CBP did reduce the expression of selected target genes. It will be fascinating to probe this effect further, and to discover whether the presence of CBPbound RNAs is an improved determinant of where CBP is actively modulating gene transcription.
The authors' work suggests a mechanism for region-specific control of CBP, resolving how CBP can be bound throughout the genome, but active only at a subset of sites. A similar finding has been reported 9 for another defining characteristic of enhancers, methylation of the amino-acid residue lysine 4 on histone H3, which also depends on the onset of eRNA synthesis. Interestingly, Bose et al. found that depletion of CBP did not have consistent effects on eRNA production, implying that eRNA transcription occurs early in enhancer activation, often independently of CBP activity and histone acetylation levels. Thus, acetylation by CBP may be more important for maintaining enhancer activity than for initiating the process.
A model is emerging in which transcription is itself an early step in enhancer activation. Pol II is recruited by transcription factors and maintains opens chromatin 10 . Once the enzyme begins to transcribe, the nascent eRNA it produces stimulates co-activator proteins such as CBP in the region in a sequenceand stability-independent manner. The activities of these proteins promote the recruitment of more transcription factors, Pol II and chromatin-remodelling proteins, enabling full enhancer activation. In addition, Pol II itself can serve as a vehicle for attracting chromatin-modifying enzymes that spread more molecular marks associated with chromatin activation across the transcribed region 10 . In this manner, transcription of enhancers can generate a positive-feedback loop that stabilizes both enhancer activity and gene-expression profiles.
Overall, the current study fundamentally It is natural to ask whether one can also spontaneously break the time-translational symmetry of the laws of physics -as far as these laws are concerned, any time is as good as any other. In 2012, the physicist Frank Wilczek proposed 1 the first concrete ideas about such a time crystal. Although subsequent work showed that time crystals, as initially envisaged, were unstable [2] [3] [4] , the idea has recently been rebooted as a Floquet time crystal [5] [6] [7] [8] . On pages 217 and 221, Zhang et al. 9 and Choi et al. 10 report experimental evidence for this exotic state of matter.
To understand Floquet time crystals, it is useful to consider the surface of a crystal. Because of the underlying spatial ordering of the atoms in a crystal, the surface possesses a discrete translational symmetry. When atoms of a different element are adsorbed on the surface, they could inherit the surface's crystal symmetry or they might, instead, form an atomic layer that has lower translational symmetry -for example, by occupying only alternating adsorption sites. If the latter occurs, the surface's discrete translational symmetry is spontaneously broken. Similarly, a system that is pumped periodically will have a discrete time-translational symmetry. If this symmetry is spontaneously broken, a Floquet time crystal results.
A potential problem with this idea is that the periodic drive is expected to heat up the system continually 11 , thereby precluding any kind of ordered state. However, researchers have discovered two loopholes. First, if the frequency of the drive is large compared to the local energy scales of the system, heating occurs slowly and there is a long-lived quasi-steady state, called a pre-thermal state 12 , in which non-trivial states of matter can manifest 13 . Second, if the system has a high density of immobile impurities, then a phenomenon called many-body localization 14 can occur, in which the necessary spreading of energy cannot take place because the impurities trap excitations. In this case, heating doesn't happen at all 15 and exotic states of matter such as a Floquet time crystal can survive indefinitely 6 .
In the canonical theoretical model of a Floquet time crystal [6] [7] [8] , a set of magnetic moments (spins) interact through a ferromagnetic interaction in the presence of a random-strength magnetic field nearly aligned with their preferred axis (Fig. 1) . The spins are then subjected to a temporary magnetic field perpendicular to their preferred axis, called an approximate π-pulse, whose strength and duration are sufficient to rotate the spins by approximately 180° -but not necessarily exactly 180°. These two steps are repeated cyclically to form a periodic drive.
If the ferromagnetic interaction is weak, the spins relax at late times to a state that has the periodicity of the drive -except in the finetuned case of an exact π-pulse. However, if the interaction is strong, the spins flip precisely changes the discourse around eRNA functions, by demonstrating that these RNAs can have major, locus-specific roles in enhancer activity that do not require a particular RNA-sequence context or abundance. Furthermore, by providing strong evidence that CBP interacts with eRNAs as they are being transcribed, this study highlights the value of investigating nascent RNAs for understanding enhancer activity. ■ 
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